Viewing Study NCT07244666


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-01-07 @ 12:37 PM
Study NCT ID: NCT07244666
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-24
First Post: 2025-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module